Abstract
Previously reported co-occurrence of colorectal cancer (CRC) and tooth agenesis (TA) and the overlap in disease-associated gene variants suggest involvement of similar molecular pathways. In this study, we took an unbiased approach and tested genome-wide significant CRC-associated variants for association with isolated TA. Thirty single nucleotide variants (SNVs) in CRC-predisposing genes/loci were genotyped in a discovery dataset composed of 440 individuals with and without isolated TA. Genome-wide significant associations were found between TA and DUSP10 rs6687758 (P=1.25 × 10−9) and ATF1 rs11169552 (P=4.36 × 10−10), with strong association found with CASC8 rs10505477 (P=8.2 × 10−5). Additional CRC marker haplotypes were also significantly associated with TA (P<0.0002). Genotyping an independent dataset consisting of 52 cases with TA and 427 controls confirmed the association with CASC8.
Atf1 and Dusp10 expression was detected in the mouse developing teeth from early bud stages to the formation of the complete tooth, suggesting a potential role for these genes and their encoded proteins in tooth development. Our findings suggest Atf1 and Dusp10 as new tooth development genes, while having a role in colorectal cancer. While their individual contributions in tooth development remain to be elucidated, these genes may be considered additional candidates to be tested in future human genetic studies.
Introduction
Colorectal cancer (CRC) is the third most commonly diagnosed cancer in the world and a leading cause of cancer-related deaths.(Navarro et al. 2017) Its etiology is multifactorial and ~33% of all cases are attributed to genetic factors.(Siegel et al. 2014) Tooth agenesis (TA), the congenital absence of one or more permanent teeth, results from disturbances during the initiation stage of tooth development, and represents one of the most common craniofacial anomalies in humans.(Hennekam 2010) Over a decade ago, Lammi et al.(Lammi et al. 2004) reported that mutations in the tumor suppressor gene AXIN2 were found co-segregating with colorectal cancer and tooth agenesis in a large multiplex family. Moreover, these authors showed the expression of AXIN2 in developing mouse teeth and suggested that genes involved in colorectal cancer could also be involved in tooth development. (Lammi et al. 2004)
Tooth development requires a sophisticated series of signaling interactions between the oral epithelium and mesenchyme under strict genetic control by a number of signaling molecules and their downstream signaling pathways.(Thesleff and Sharpe 1997) Any alteration of the epithelial-mesenchymal interactions can have deleterious effects on tooth development, and may affect growth, differentiation and pattern formation, or even have systemic effects.(Cudney and Vieira 2012; Yin and Bian 2015) TA can occur as part of a syndrome, although it is more frequently found as an isolated trait that may appear sporadically or segregating in families, for which the prevalence ranges between ~2-10% excluding third molars.(Polder et al. 2004) Based on the number of missing teeth, TA is referred to as hypodontia (up to 5 teeth missing), oligodontia (≥6 teeth missing), or anodontia (all teeth missing), the latter being mostly associated with syndromic TA.(Hennekam 2010)
Studies in mice have revealed more than 200 genes involved in tooth development and shown the functional importance of Msx1, Pax9, Pitx2, and Lef1 genes in proper tooth formation and morphogenesis, since the absence of these genes results in arrest of tooth development at the bud stage.(Thesleff et al. 1996) In humans, the best characterized mutations involve MSX1, PITX2, and PAX9.(Li et al. 2014; Thesleff et al. 1996) Additional mutations in Wnt pathway genes (i.e., AXIN2, LRP6, WNT10A, WNT10B) have been increasingly implicated in the susceptibility to TA.(Yin and Bian 2015) Intriguingly, it is well established that Wnt pathway genes also play critical roles in tumorigenesis, particularly in colorectal cancer. (Callahan et al. 2009; Lammi et al. 2004; Letra et al. 2009; Yin and Bian 2016)
In addition to epithelial-mesenchymal interactions, cell growth and cell differentiation, the signaling pathways involved in tooth development (i.e., WNT, BMP, SHH, FGF, TGF-β, and NF-kB), also overlap with those implicated in colorectal cancer.(Cudney and Vieira 2012; Yin and Bian 2015) Recently, genome-wide association studies (GWAS) have uncovered over 50 loci and single nucleotide polymorphisms (SNPs) that are significantly correlated with the susceptibility to CRC, most of which map to genes with established roles in tumorigenesis, or involved in developmental processes such as transcriptional regulation, genome maintenance, and cell growth and differentiation.(Hsu et al. 2015; Kang et al. 2015; Zhang et al. 2014) Of note, SNPs in CDH1, BMP2, BMP4, and GREM1 genes, known to have important roles in craniofacial and/or tooth development, (Cudney and Vieira 2012) were also reported as highly associated with CRC.(Cudney and Vieira 2012; Zhang et al. 2014)
Given the previously reported co-occurrence of CRC and TA and the overlap in disease-associated pathways, we sought to identify new genes for TA by testing the association of genome-wide associated CRC variants with isolated TA. Here, we describe the identification of new candidate genes for TA by the combination of an unbiased association study as well as expression analyses in oral and dental tissues of mouse embryos.
Materials and Methods
Study Population
This study was approved by the University of Texas Health Science Center at Houston Committee for the Protection of Human Subjects and the University of Pittsburgh Institutional Review Board. Unrelated individuals with and without tooth agenesis were invited to participate in the study when presenting for treatment at the University of Texas Health Science Center at Houston School of Dentistry clinics. Written informed consent was obtained from all participating individuals and/or from their parents or guardians. Clinical and demographic information, and saliva samples were collected from all individuals. When available, individual and familial history of cancer was also recorded. The presence of tooth agenesis was determined by a dentist through clinical and radiographic examinations, and considered if one or more permanent teeth were missing from the oral cavity excluding third molars. Individuals showing signs of syndromic forms of tooth agenesis (i.e., ectodermal dysplasia features) were excluded. To avoid potential effects of population stratification, only individuals with self-reported Caucasian ethnicity were included in the study. A total of 440 unrelated individuals, 93 with nonsyndromic TA (29 males, 64 females) and 347 control individuals without TA or family history of TA (101 males, 246 females) were included in this study. Of the 93 cases with TA, 61 presented with hypodontia while 32 presented with oligodontia. Positive family history of cancer was reported by 28 cases and 33 control individuals (Supplementary Material, Table S1).
Selection of CRC-Associated Variants and Genotyping
We selected 30 CRC-risk-associated SNPs that reached genome-wide significance (5 × 10-8) in previously published GWAS (Houlston et al. 2010; Hsu et al. 2015; Lemire et al. 2015) to genotype in this study (Table 1). For regions where multiple SNPs have been reported, we included the most significantly-associated SNP according to the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO; https://share.fhcrc.org/sites/gecco/), and prioritized additional SNPs for genotyping based on: 1) location in regulatory or enhancer regions of a given gene, 2) having an effect on motifs in the distal regulatory regions of respective genes, and/or 3) interactions with known genes of biological relevance.
Genotyping was performed using Taqman chemistry (Ranade et al. 2001) in 5-μL final reaction volumes in a ViiA7 Sequence Detection System (Applied Biosystems, Foster City, CA). Results were analyzed using EDS v.1.2.3 software (Applied Biosystems). For quality control of genotyping reactions, we used a non-template reaction as negative control and a DNA sample of known genotype as positive control. The call rate of genotyped SNPs was considered as >95% accurate.
Data analyses
Power calculations were performed using Genetic Power Calculator (http://zzz.bwh.harvard.edu/gpc/) and indicate that the study sample size provided approximately 86% power to detect an association with an alpha of 0.05, if the markers selected are in linkage disequilibrium with the causal factor (D’=0.80) and their frequencies are around 80%. Data analysis was performed using PLINK version 1.06.(Purcell et al. 2007) Hardy-Weinberg equilibrium was calculated for cases and controls, and SNPs showing evidence of deviation in controls were excluded from further analyses. Differences in allele and genotype frequencies for each polymorphism between cases and controls were compared using chi-square and Fisher Exact tests. We corrected for multiple testing using the Bonferroni method, and the significance level was set considering the number of tests (n=30) to give a corrected P-value (α=0.002). Haplotype analyses were performed using the ‘haplotype-based case-control association test’ as implemented in PLINK. Regression analyses were performed using EpiInfo v.7.1 (https://www.cdc.gov/epiinfo/) to identify potential preferential associations between specific SNP genotypes with tooth agenesis adjusted for family history of cancer and gender.
In silico prediction of SNP function
Annotation of the newly identified loci was performed using the dbNSFP (Liu et al. 2016) and FuncPred (https://snpinfo.niehs.nih.gov/snpinfo/snpfunc.html) databases. Information on the function of the associated SNPs regarding splicing regulation, stop codon, Polyphen predictions, transcription factor binding site predictions, miRNA binding site prediction regulatory potential score, conservation score, and nearby genes, were recorded.
Immunofluorescence and immunohistochemistry
The expression of ATF1 and DUSP10 proteins was evaluated using immunofluorescence and immunohistochemistry in developing mouse tooth sections, respectively. Wild type C57BL/6 mouse embryos at embryonic days (E) 12.5, 14.5, 16.5, 18.5 and postnatal day 0 (P0) were harvested, fixed in 4% paraformaldehyde and embedded in paraffin for sectioning at 7μm of thickness. Sections were deparaffinized in xylene solution, rehydrated in gradative alcohol baths and rinsed with deionized H2O at room temperature. For antigen retrieval, sections were immersed in sodium citrate buffer (10mM, pH 6) at 100°C for 30 minutes and allowed to cool down for 30 min at room temperature. To avoid nonspecific binding of the antibodies, sections were immersed in blocking solution (1% bovine serum albumin and 10% goat serum diluted inPBS) and incubated with AffiniPure Fab fragment goat anti-mouse (Jackson ImmunoResearch Laboratories, PA, USA), for 1 hour at room temperature. For DUSP10, an additional blocking step consisted of incubating sections in 2.5% normal horse serum (Vector Laboratories, CA, USA) for 30 min at room temperature. Sections were then washed and incubated with either Atf1 (rabbit polyclonal anti-mouse Atf1; ab189311, Abcam, MA, USA), or Dusp10 (rabbit polyclonal anti-mouse Dusp10; ab71309, Abcam, MA, USA) primary antibodies at 4o C overnight. For Atf1, sections were then washed and incubated with Alexa Fluor® 555 (goat anti-rabbit secondary antibody, A-21428, ThermoFisher Scientific, MA, USA) for 2 hours in a dark chamber at room temperature. Lastly, sections were washed (3 × 10’), counterstained with DAPI (Invitrogen) in a dark chamber for 10 min, and mounted with ProLong Gold AntifadeReagent (Invitrogen). For Dusp10, sections were incubated with biotinylated horse anti-rabbit IgG (BP-1100, Vector Laboratories, CA, USA) for 30 minutes at room temperature, washed and incubated with Streptavidin/Peroxidase complex (PK7800, Vector Laboratories, CA, USA) for 5 minutes and washed. Sections were then incubated in 3,3'-Diaminobenzidine (ImPACT DAB, Vector Laboratories, CA, USA) chromogen for 2 minutes, washed, and counterstained with Mayer’s Hematoxylin. Lastly, sections were washed, dehydrated and mounted.Imaging was performed after 48 hours in a Nikon Eclipse Ni-U upright fluorescence microscope (Nikon, Germany) equipped with a Zyla 5.5 sCMOS camera (Andor).
Reverse transcriptase-PCR (RT-PCR)
Total RNA was extracted from SCAP by using the RNeasy kit (Qiagen Inc, Valencia, California, USA). RNA sample integrity was checked by analyzing 1 μg of total RNA on 2100 Bioanalyzer (Agilent Technologies, Santa Clara, California, USA). After RNA extraction, complementary DNA was synthesized by using 3 μg of RNA through a reverse transcription reaction using QuantiTectRT kit (Qiagen Inc, Valencia, California, USA). Four sets of primers for CASC8 amplification were designed using Primer3 (http://bioinfo.ut.ee/primer3-0.4.0/primer3/) (Supplementary Material, Table S4). β-actin (Actb) was used as endogenous control. PCR reactions were performed in 25uL final reaction volume using 20ng of SCAP cDNA, 1uL of each forward and reverse primers, 0.5uL Taq DNA polymerase, MgCl2, deoxynucleotide mix, 10X PCR buffer, and water. Reaction conditions were: 40 cycles at 95°C (10’), 94°C (1’), 56°C (1’), and 72°C (2’). Products were resolved in agarose gel electrophoresis and imaged using Odyssey Scanner (LI-COR Biosciences, Lincoln, NE).
Results
GWAS-based association study
A total of 440 unrelated individuals, 93 with nonsyndromic TA (29 males, 64 females) and 347 control individuals without TA or family history of TA (101 males, 246 females) were included in this study. The presence of tooth agenesis was determined through clinical and radiographic examinations, and considered if one or more permanent teeth were missing from the oral cavity excluding third molars. Individuals showing signs of syndromic forms of tooth agenesis (i.e., ectodermal dysplasia features) were not included in the study. Of the 93 cases with TA, 61 presented with hypodontia while 32 presented with oligodontia. Positive family history of cancer was reported by 28 cases and 33 control individuals.
We selected 30 CRC-predisposing SNVs with genome-wide significance (5 × 10−8) from previously published GWAS (Houlston et al. 2010; Hsu et al. 2015; Lemire et al. 2015), for genotyping in our case-control dataset (Table 1). For regions where multiple SNPs have been reported, we included the most significantly-associated SNP according to the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO; https://share.fhcrc.org/sites/gecco/), and prioritized additional SNPs for genotyping based on: 1) location in regulatory or enhancer regions of a given gene, 2) having an effect on motifs in the distal regulatory regions of respective genes, and/or 3) interactions with known genes of biological relevance. Genotypes were generated using Taqman chemistry (Ranade et al. 2001) and automatic call rate was >98%.
Genome-wide significant associations were found between TA and individual SNPs on 1q41 and 12q13 (Table 2). At the 1q41 locus, rs6687758 is located downstream of the dual specificity phosphatase 10 (DUSP10) gene, and allelic (P= 2 × 10−9) and genotypic (P= 1.25 × 10−9) associations were found between this SNP and TA, particularly under a recessive model (P= 1.27 × 10−9). At the 12q13.1 locus, rs11169552 is located 2Kb upstream of the activating transcription factor 1 (ATF1) gene promoter, for which genome-wide genotypic (P= 4.36 × 10−10) and significant allelic associations (P=1.87 × 10-7) were also found (Table 2). Strong association was also found between intronic variants in the cancer susceptibility 8 (CASC8) gene on chromosome 8q24 and TA for SNP rs10505477 genotypes and alleles (P= 8.16 × 10−5 and P= 1.7 × 10−5, respectively) and rs7014346 (P=0.0005 for genotype under a recessive model) (Table 2). When stratifying analyses by cases with hypodontia or oligodontia phenotypes, these associations remained significant for both phenotypes, despite the smaller number of oligodontia cases (P ≤ 0.002, data not shown). Additional significant haplotype associations were also found between markers in the associated genes with the risk of isolated TA (Supplementary Material, Table S2). The strongest association was observed for the G-A-G allele haplotypes from CASC8 SNPs rs10505477, rs7013436, and rs6983267 (P= 5 × 10−13), followed by the G-G haplotype from DUSP10 rs6687758 and rs6691170 (P = 7.32 × 10−10). Additional nominal associations were found for ATF1 haplotypes (P≤ 0.009) (Table S2). Interestingly, significant associations were found between the ‘TT’ genotype for ATF1 rs11169552 (P=0.00004) and the ‘GG’ genotype for DUSP10 rs6687758 (P=0.003) with TA phenotypes in the presence of positive family history of cancer (Supplementary Material, Table S3).To confirm our findings, we genotyped the associated SNPs on an independent dataset composed of 52 cases with tooth agenesis and 427 gender- and ethnicity-matched unrelated controls, and found significant association between CASC8 rs10505477 (P=0.006 for genotype and P=0.008 for allele) and TA, particularly under a dominant model (P= 0.001).
Functional annotation of associated variants
As a first step into assessing the relevance of the associated genes in tooth agenesis phenotypes, we annotated the associated variants using the dbSNP database (Liu et al. 2016) to predict gene and variant function. Our analyses showed that the associated variants, although common, are predicted to have effects on chromatin structure and RNA polymerase activity and on transcription of their respective genes. ATF1 rs11169552 is located in the gene promoter in a region showing high DNase I hypersensitivity clusters and potential location of regulatory elements (enhancers, silencers, insulators, and locus control region) (Fig. S4). Further, ATF1 rs11169552 is predicted to harbor a binding site for POLR2A, essential for RNA polymerase activity and DNA transcription. DUSP10 rs6687758 is located in a DNAse I hypersensitivity cluster with binding motif for TBP (TATA-box binding protein) (Fig. S5). CASC8 rs10505477 appears to harbor a putative binding motif to NK2-5, in a region of enriched H3K27Ac histone marks (Supplementary Material, Fig. S6). These findings suggest that these variants are likely to have functional consequences on gene expression.
Expression analyses
Since no information was available from public databases regarding the expression of ATF1, DUSP10 and CASC8 during tooth development, as a second step into determining the relevance of these genes in tooth development, we sought to assess whether their transcripts and/or encoded proteins were expressed in the oral and dental tissues of developing mouse embryos.
We performed immunofluorescence and immunohistochemistry procedures to detect the localization of Atf1 and Dusp10, respectively, during murine tooth development stages. At E12.5, Atf1 expression was detected in the oral epithelial cells and in the subjacent condensed ectomesenchymal cells (Figures 1A and 1C). Later, at E14.5, Atf1 expression was evident in the oral and tongue epithelia, and underlying mesenchyme, in the inner dental epithelium (IE) and in few scattered cells of the dental papilla (DP) (Fig. 1, D-E). At E16.5 (Supplementary Material, Fig. S2), and E18.5, Atf1 was markedly expressed in the inner epithelium and the stratum intermedium. Reduced expression was also noted in the cells from the stratum intermedium, stellate reticulum and outer dental epithelium (Figures 1F and 1H). At P0, Atf1 expression shifted to the cytoplasm of the polarized layer of ameloblasts, in a perinuclear pattern in the ameloblast bodies, as well as in the Tomes’ processes (Figures 1I and 1J). Atf1 mRNA expression had been shown to be expressed in mouse embryos as early as E10.5, with strong expression noted in the mesenchyme of frontonasal prominences, branchial arches and limbs (Gray et al. 2004) (Figure 1K). Dusp10 expression was detected at a site of proliferation of the dental placode at E12.5, surrounded by a condensation of the underlying ectomesenchymal cells compatible with a bud stage of tooth development. Expression was evident in the epithelial cells from the oral epithelium, as well as in the condensed ectomesenchymal cells surrounding the epithelial proliferation (Figures 2A and 2B). At E14.5, nuclear and cytoplasmic staining was observed on the cells from the enamel organ and dental papillae (Figures 2C and 2D). At bell stage E16.5, positive staining was observed in the enamel organ, dental papillae and dental follicle cells (Figures 2E and 2F). At 18.5, Dusp10 expression was noted in the enamel organ, in the ectomesenchymal cells of the dental papillae and the dental follicle cells (Figures 2G and 2H). Later, at P0, Dusp10 expression was localized to the preameloblasts, odontoblasts and pre-dentin (Figures 2I and 2K). Marked expression was noted in the nuclei and cytoplasms of preameloblasts, as well as in the subjacent odontoblast layer (Figure 2K). Dusp10 mRNA expression was observed in the mouse craniofacial region and oral cavity at E14.5, particularly in the mouth and tongue.(Hoffman et al. 2008) (Figure 2L). These data suggested that Atf1 and Dusp10 are present throughout tooth development stages in mouse embryos and thus likely to have a role in tooth development. Therefore, variations that impact the function of ATF1 and DUSP10 in humans are likely to play a contributory role in tooth agenesis.
CASC8 has only recently been annotated in the human genome, and not yet in the mouse genome, and thus limited our analysis to evaluate its expression in relevant tissues. Using information available in public databases, we found that CASC8 mRNA is expressed in many tissues including brain and skin, and over-expression was noted in minor salivary gland, colon and esophagus. We then performed RT-PCR analysis of CASC8 expression in stem cells of the apical papilla (SCAP), a dental-derived stem cell line, (Liu et al. 2006) however, no expression was detected.
Discussion
Over a decade ago, Lammi et al. (Lammi et al. 2004) identified AXIN2 as a novel gene involved in tooth development after finding mutations in this gene to be co-segregating with CRC and TA in a large multiplex family. Moreover, these authors showed the expression of Axin2 in developing mouse teeth and showed for the first time that a gene involved in CRC could also be involved in tooth development. Here, we report the unbiased discovery of new CRC-predisposing genes with a role in tooth development as well as additional candidate variants for isolated TA.
Our association analyses revealed genome-wide significant associations between TA and loci on 1q41, 8q24, and 12q13, containing DUSP10 (dual specificity phosphatase 10), CASC8 (cancer susceptibility candidate 8), and ATF1 (activating transcription factor 1) genes, respectively.
ATF1 belongs to the ATF/CREB family of transcription factors, which binds to the consensus ATF/CRE site ‘TGACGTCA’ and regulates the transcription of target genes to participate in various cellular processes.(Hai and Hartman 2001) Previous reports showed that the function of ATF1 appears to depend on the cellular and genetic context to play an important role in tumor progression in a tumor-specific manner.(Huang et al. 2012) ATF1 was found to be over-expressed in several cancer types including lymphoma, melanoma and nasopharyngeal carcinoma, and functioned as a tumor promoter both in vitro and in vivo.(Hsueh and Lai 1995; Huang et al. 2016; Jean and Bar-Eli 2000; Su et al. 2011) In contrast, disruption of ATF1 activity suppressed its tumorigenicity and metastatic potential.(Jean and Bar-Eli 2000) However, the exact role of ATF1 during craniofacial development is still largely unknown. Loss of Atf1 in mice did not cause any obvious phenotypic abnormalities although led to increased programmed cell death.(Bleckmann et al. 2002)
DUSP10 is a dual specificity phosphatase (DUSP) that negatively regulates the activation of the mitogen-activated protein kinase (MAPK) gene family, which includes the extracellular-regulated kinases (ERKs) and the stress-activated protein kinases p38 and c-Jun NH2-terminal kinase (JNK). Activation of MAPK by various stimuli including growth factors, cytokines, or stress conditions, regulates major cellular responses such as proliferation, differentiation, survival, migration or production of soluble factors.(Bermudez et al. 2010) Dusp10 has been regarded as an important regulator of tumorigenesis in animal models,(Png et al. 2016) and loss of Dusp10 in mice caused enhanced immune and inflammatory responses although effects on skeletal phenotype have not been described.(Zhang et al. 2004) Nonetheless, other DUSPs have been found to play critical roles in development. Loss of function studies revealed that Dusp4 is essential for early development and endoderm specification in the zebrafish,(Brown et al. 2008) whereas Dusp5 was described to control angioblast populations in the lateral plate mesoderm.(Pramanik et al. 2009)
CASC8 is a long noncoding RNA (lncRNA), located in the gene desert region on 8q24.21. LncRNA is a new class of transcripts that are involved in multiple cellular functions including the regulation of expression of multiple genes. Studies have shown that SNPs in lncRNAs may affect the biological processes of messenger RNA conformation, and results in the modification of its interacting partners. Interestingly, various cancer types, including CRC, prostate, breast and gastric cancer, have been reported in association with CASC8, (Lemire et al. 2015; Yao et al. 2015) possibly through its function as a lncRNA.
Variants in ATF1, DUSP10 and CASC8 have been associated with increased risk of CRC in different GWAS with multiple populations, (Houlston et al. 2010; Hsu et al. 2015; Lemire et al. 2015) although functional studies addressing the potential effects of these variants on gene function and/or disease mechanisms are scarce. While the biological function of the associated ATF1, DUSP10, and CASC8 variants is yet to be determined, our bioinformatics analyses revealed that all three variants are predicted to be within DNAse I hypersensitivity clusters, or in enhancer histone marks, with likely functional effects on gene expression. Moreover, ATF1 rs11169552 is predicted to harbor a binding site for POLR2A, essential for RNA polymerase activity and DNA transcription. Another regulatory variant in ATF1 (rs11169571) was shown to increase breast/ovarian cancer risk through modifying miRNA binding.(Kontorovich et al. 2010; Yang et al. 2015) Interestingly, this variant is in linkage disequilibrium with ATF1 rs11169552, associated in the present study, and could be transmitting the same genetic information as well as functional potential. DUSP10 rs6687758 is predicted to have a putative binding motif for TBP (TATA-box binding protein), which controls the transcription machinery. CASC8 rs10505477 has a putative binding motif to NK2-5, a homeobox-containing transcription factor with roles in embryonic development. These findings suggest that these genes are active in early cell processes being important in both embryogenesis and tumorigenesis.
The relevance of ATF1, DUSP10 and CASC8 in tooth development is unknown. Therefore, we assessed the expression of these genes or their encoded proteins in relevant tissues or cell lines. During mouse embryonic development, Atf1 mRNA was detected at embryonic day 10.5, with strong expression noted in the mesenchyme of the frontonasal prominences, branchial arches and limbs (Gray et al. 2004). Our findings showed that Atf1 is expressed throughout mouse tooth development stages, in the oral epithelial cells and subjacent condensed ectomesenchymal cells during the early bud stage of tooth development, then shifting to the inner dental epithelium and dental papilla, and finally in the ameloblasts at the final stages of tooth development. Dusp10 mRNA expression was also observed in the mouse craniofacial region and oral cavity at E14.5, particularly in the mouth and tongue. (Hoffman et al. 2008) In our study, the expression of Dusp10, albeit weak, was also noted in the proliferating dental tissues at the early stages of tooth development. At later stages, Dusp10 expression was evident in the enamel organ, pre-ameloblasts and odontoblastic layer. Expression of CASC8 mRNA has been observed in the brain and skin, and over-expression noted in minor salivary gland, colon and esophagus. However, no expression of CASC8 was detected in human dental stem cells of the apical papilla (SCAP). Since CASC8 has only recently been annotated in the human genome, we were limited in the choice of relevant tissues to assess its expression thus hampering our interpretation of the role of this gene in tooth development. Of note, the observed association between TA and the CASC8 locus on chromosome 8q24.21 raises intriguing questions as this locus has been associated with increased risk of several malignancies including CRC (Lemire et al. 2015; Yao et al. 2015) and also cleft lip/palate,(Birnbaum et al. 2009; Yu et al. 2017) for which an expanded phenotype including tooth agenesis has been proposed.(Letra et al. 2007)
To date, no large-scale, unbiased genetic studies have been conducted to elucidate the full spectrum of common variants associated with isolated TA, some of which may be located in genes/pathways yet unknown for a role in tooth development. Our findings provide evidence that unbiased approaches have the potential to elucidate the full spectrum of variants associated with TA. It is possible that the associated variants in the present study may be in linkage disequilibrium with a distant causal variant, and acting as surrogate markers for the condition. Additional fine-mapping around the associated loci may provide additional insights into the association signal. Finally, while the exact contributions of ATF1, DUSP10 and CASC8 in tooth agenesis remain to be further elucidated, our findings further support that genes involved in colorectal cancer may also be involved in tooth development and provide additional insights into deciphering the complex etiology of the condition.
Funding
This work was supported in part by funding from the National Institute for Dental and Craniofacial Research (NIDCR) (R03-DE024596 to A.L., and R90 DE024296-03 to M.R.B.); American Association of Orthodontists (Foundation Biomedical Research Award to S.A. and A.L.); the Rolanette and Berdon Lawrence Bone Disease Program of Texas (to W.D.F.), and the Scientific and Technological Research Institution of Turkey, TUBITAK-ERA NET (CRANIRARE-2, grant number: SBAG-112S398), Istanbul University Research Fund (Project No: 48398). M.W.W. was supported by the UTSD Summer Research Program. Data and samples from Pittsburgh were sourced through the Dental Registry and DNA Repository project, which is supported by the University of Pittsburgh School of Dental Medicine.
Conflict of Interest
The authors have no conflict of interest to declare.
Acknowledgements
We thank the study individuals for participation in this study. This work was supported in part by funding from the National Institute for Dental and Craniofacial Research (NIDCR) (R03-DE024596 to A.L., and R90 DE024296-03 to M.R.B.); American Association of Orthodontists (Foundation Biomedical Research Award to S.A. and A.L.); the Rolanette and Berdon Lawrence Bone Disease Program of Texas (to W.D.F.), and the Scientific and Technological Research Institution of Turkey, TUBITAK-ERA NET (CRANIRARE-2, grant number: SBAG-112S398), Istanbul University Research Fund (Project No: 48398). M.W.W. was supported by the UTSD Summer Research Program. Data and samples from Pittsburgh were sourced through the Dental Registry and DNA Repository project, which is supported by the University of Pittsburgh School of Dental Medicine.